BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28496991)

  • 1. TORC1 coordinates the conversion of Sic1 from a target to an inhibitor of cyclin-CDK-Cks1.
    Moreno-Torres M; Jaquenoud M; Péli-Gulli MP; Nicastro R; De Virgilio C
    Cell Discov; 2017; 3():17012. PubMed ID: 28496991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TORC1 controls G1-S cell cycle transition in yeast via Mpk1 and the greatwall kinase pathway.
    Moreno-Torres M; Jaquenoud M; De Virgilio C
    Nat Commun; 2015 Sep; 6():8256. PubMed ID: 26356805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-negative feedback between S-phase cyclin-CDK and CKI generates abruptness in the G1/S switch.
    Venta R; Valk E; Kõivomägi M; Loog M
    Front Physiol; 2012; 3():459. PubMed ID: 23230424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of sic1, a cyclin-dependent kinase (Cdk) inhibitor, by Cdk including Pho85 kinase is required for its prompt degradation.
    Nishizawa M; Kawasumi M; Fujino M; Toh-e A
    Mol Biol Cell; 1998 Sep; 9(9):2393-405. PubMed ID: 9725902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIC1 is ubiquitinated in vitro by a pathway that requires CDC4, CDC34, and cyclin/CDK activities.
    Verma R; Feldman RM; Deshaies RJ
    Mol Biol Cell; 1997 Aug; 8(8):1427-37. PubMed ID: 9285816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapamycin-mediated G1 arrest involves regulation of the Cdk inhibitor Sic1 in Saccharomyces cerevisiae.
    Zinzalla V; Graziola M; Mastriani A; Vanoni M; Alberghina L
    Mol Microbiol; 2007 Mar; 63(5):1482-94. PubMed ID: 17302822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cascades of multisite phosphorylation control Sic1 destruction at the onset of S phase.
    Kõivomägi M; Valk E; Venta R; Iofik A; Lepiku M; Balog ER; Rubin SM; Morgan DO; Loog M
    Nature; 2011 Oct; 480(7375):128-31. PubMed ID: 21993622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saccharomyces cerevisiae Ime2 phosphorylates Sic1 at multiple PXS/T sites but is insufficient to trigger Sic1 degradation.
    Sedgwick C; Rawluk M; Decesare J; Raithatha S; Wohlschlegel J; Semchuk P; Ellison M; Yates J; Stuart D
    Biochem J; 2006 Oct; 399(1):151-60. PubMed ID: 16776651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of the Sic1 inhibitor of B-type cyclins in Saccharomyces cerevisiae is not essential but contributes to cell cycle robustness.
    Cross FR; Schroeder L; Bean JM
    Genetics; 2007 Jul; 176(3):1541-55. PubMed ID: 17483408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The yeast cyclin-dependent kinase inhibitor Sic1 and mammalian p27Kip1 are functional homologues with a structurally conserved inhibitory domain.
    Barberis M; De Gioia L; Ruzzene M; Sarno S; Coccetti P; Fantucci P; Vanoni M; Alberghina L
    Biochem J; 2005 May; 387(Pt 3):639-47. PubMed ID: 15649124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hog1 mediates cell-cycle arrest in G1 phase by the dual targeting of Sic1.
    Escoté X; Zapater M; Clotet J; Posas F
    Nat Cell Biol; 2004 Oct; 6(10):997-1002. PubMed ID: 15448699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDK Pho85 targets CDK inhibitor Sic1 to relieve yeast G1 checkpoint arrest after DNA damage.
    Wysocki R; Javaheri A; Kristjansdottir K; Sha F; Kron SJ
    Nat Struct Mol Biol; 2006 Oct; 13(10):908-14. PubMed ID: 16964260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new linear cyclin docking motif that mediates exclusively S-phase CDK-specific signaling.
    Faustova I; Bulatovic L; Matiyevskaya F; Valk E; Örd M; Loog M
    EMBO J; 2021 Jan; 40(2):e105839. PubMed ID: 33210757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective degradation of ubiquitinated Sic1 by purified 26S proteasome yields active S phase cyclin-Cdk.
    Verma R; McDonald H; Yates JR; Deshaies RJ
    Mol Cell; 2001 Aug; 8(2):439-48. PubMed ID: 11545745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linkage of replication to start by the Cdk inhibitor Sic1.
    Schneider BL; Yang QH; Futcher AB
    Science; 1996 Apr; 272(5261):560-2. PubMed ID: 8614808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct activities of the related protein kinases Cdk1 and Ime2.
    Sawarynski KE; Kaplun A; Tzivion G; Brush GS
    Biochim Biophys Acta; 2007 Mar; 1773(3):450-6. PubMed ID: 17137646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cyclin-dependent kinase inhibitor p40SIC1 imposes the requirement for Cln G1 cyclin function at Start.
    Tyers M
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7772-6. PubMed ID: 8755551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sic1 as a timer of Clb cyclin waves in the yeast cell cycle--design principle of not just an inhibitor.
    Barberis M
    FEBS J; 2012 Sep; 279(18):3386-410. PubMed ID: 22356687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greatwall-Endosulfine: A Molecular Switch that Regulates PP2A/B55 Protein Phosphatase Activity in Dividing and Quiescent Cells.
    García-Blanco N; Vázquez-Bolado A; Moreno S
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31835586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK2 regulates in vitro the activity of the yeast cyclin-dependent kinase inhibitor Sic1.
    Barberis M; Pagano MA; Gioia LD; Marin O; Vanoni M; Pinna LA; Alberghina L
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1040-8. PubMed ID: 16168390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.